Abstract
The physiological functions of various organs and tissues are thought to be regulated by a paracrine system employing a number of growth factors and cytokines, as well as by the nerve and endocrine systems. Recently, a reciprocal relationship between endocrine and immune functions has become apparent in the female reproductive system with respect to ovarian and uterine functions. Furthermore, a number of cytokines have been identified that are produced in the female reproductive organs. Of the various cytokines known to be produced in the uterus, it is suggested that macrophage colony stimulating factor (M-CSF) (1, 2), stem cell factor (SCF) (3, 4), leukemia inhibitory factor (LIF) (5, 6), and transforming growth factor β (TGFβ) (7)are thought to stimulate or suppress local immune cell function and play important roles in blastocyst implantation and/or early placental development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pollard JW, Bartocci A, Arceci R, Orlofsky A, Landner MB, Stanley ER. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 1987; 330: 484–6.
Regenstreif LJ, Rossant J. Expression of the c-fms proto-oncogene and of the cytokine, CSF-1, during mouse embryogenesis. Dev Biol 1989; 133: 284–94.
Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P. Developmental expression of c-kit, a protooncogene encoded by the W locus. Development 1990; 109: 911–23.
Horie K, Fujita J, Takakura K, et al. Expression of c-kit protein during placental development. Biol Reprod 1991; 47: 614–20.
Smith AG, Nichols J, Robertson M, Rathjen PD. Differentiation inhibiting activity (DIA/LIF) and mouse development. Dev Biol 1992; 151: 339–51.
Shen MM, Leder P. Leukemia inhibitory factor is expressed by the pre-implantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA 1992; 89: 8240–4.
Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46: 561–72.
Stanley ER. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol 1985; 116: 564–87.
Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37.
Kauma SW, Aukerman SL, Eierman D, Turner T. Colony-stimulating factor-1 and c-fms expression in human endometrial tissue and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 1991; 73: 746–51.
Kanzaki H, Yui J, Iwai M, et al. The expression and localization of mRNA for colony-stimulating factor (CSF)-1 in the human term placenta. Hum Reprod 1992; 7: 563–7.
Sherr CJ, Rettenmeir CW, Sacca R, Roussel MF, Cook AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665–76.
Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER. A pregnancy defect in the osteopetrotic (oplop) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148: 273–83.
Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, Pollard JW. Expression of colony stimulating factor-1 (CSF-1) in the human uterus and placenta. J Clin Endocrinol Metab 1992; 74: 850–8.
Arceci RJ, Shanahan F, Stanley ER, Pollard JW. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci USA 1989; 86: 8812–22.
Williams DE, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63: 167–74.
Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63: 213–24.
Huang E, Nocka K, Beier D, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63: 225–33.
Kuroda H, Terada N, Nakayama H, Matsumoto K, Kitamura Y. Infertility due to growth arrest of ovarian follicles in Sl/Slt mice. Dev Biol 1988; 126: 71–9.
Nakayama H, Kuroda H, Onoue H, et al. Studies of Sl/Sld +/+ mouse aggregation chimaeras, II. Effect of the steel locus on spermatogenesis. Development 1988; 102: 117–26.
Arceci RJ, Pampfer S, Pollard JW. Expression of CSF-1/c-fms and SF/c-kit mRNA during preimplantation mouse development. Dev Biol 1992; 151: 1–8.
Horie K, Fujita J, Takakura K, et al. Expression of c-kit protein during placental development. Biol Reprod 1992; 47: 614–20.
Horie K, Fujita J, Takakura K, et al. The expression of c-kit protein in human adult and fetal tissues. Hum Reprod 1993; 11: 1955–62.
Fujita J, Onoue H, Ebi Y, Nakayama H, Kanakura Y. In vitro duplication and in vivo cure of mast-cell deficiency of Sl/Sld mutant mice by cloned 3T3 fibroblasts. Proc Natl Acad Sci USA 1989; 86: 2888–91.
Witte ON. Steel locus defines new multipotent growth factor. Cell 1990; 63: 5–6.
Sharkey AM, Jokhi PP, King A, Loke YW, Brown KD, Smith SK. Expression of c-kit and kit ligand at the human maternofetal interface. Cytokine 1994; 6: 195–205.
Gearing DP, Gough NM, King JA, et al. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 1987; 6: 3995–4002.
Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989; 143: 1163–7.
Williams RL, Hilton DJ, Pease S, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988; 336: 684–8.
Smith AG, Heath JK, Donaldson DD, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988; 336: 688–90.
Abe E, Tanaka H, Ishimi Y, et al. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 1986; 83: 5958–62.
Yamamori T, Fukada K, Aebersold R, Korsching S, Fann M-J, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 1989; 246: 1412–6.
Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA 1991; 88: 11408–12.
Stewart CL, Kasper P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76–9.
Shen MM, Leder P. Leukemia inhibitory factor is expressed by the pre-implantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA 1992; 89: 8240–4.
Kojima K, Kanzaki H, Iwai M, et al. Expression of leukemia inhibitory factor in human endometrium and decidua. Biol Reprod 1994; 50: 882–7.
Gearing DP, Thut CJ, VandenBos T, et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 1991; 10: 2839–48.
Graycar J, Miller D, Arrick B, Lyons R, Moses H, Derynck R. Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factor-β1 and -β2. Mol Endocrinol 1989; 3: 1977–86.
Chiefetz S, Hernandez H, Laiho M, ten Dijke P, Iwata K. Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 1990; 265: 20533–8.
Chegini N, Zhao Y, Williams R, Flanders C. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-β1 (TGF-β1), TGF-β2, TGF-β3, and TGF-β type II receptor messenger ribonucleic acid and protein and contains [1251]TGF 131-binding sites. Endocrinology 1994; 135: 439–49.
Kauma S, Matt D, Strom S, Eierman D, Turner T. Interleukin-1β, human leukocyte HLA-DRα transforming growth factor-β expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol 1990; 163: 130–7.
Roberts AB, Sporn MB. The transforming growth factor-βs. In: Sporn MB, Rôberts AB, eds. Handbook of experimental pharmacology: peptide growth factors and their receptors; vol 95. Heidelberg: Springer Verlag, 1990: 419–72.
Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46: 561–72.
Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extra-cellular matrix. J Biol Chem 1986; 261: 4337–45.
Ignotz RA, Massague J. Cell adhesion protein receptors as targets for trans-forming growth factor-β action. Cell 1987; 51: 189–97.
Lala PK, Graham CH. Mechanism of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev 1990; 9: 369–79.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Kanzaki, H., Mori, T. (1995). Immunological Regulation of Endometrial Function: Cytokine Production in the Human Endometrium. In: Dey, S.K. (eds) Molecular and Cellular Aspects of Periimplantation Processes. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2548-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2548-5_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7575-6
Online ISBN: 978-1-4612-2548-5
eBook Packages: Springer Book Archive